PMID- 35532797 OWN - NLM STAT- MEDLINE DCOM- 20221107 LR - 20221210 IS - 1432-0711 (Electronic) IS - 0932-0067 (Print) IS - 0932-0067 (Linking) VI - 306 IP - 6 DP - 2022 Dec TI - A machine learning approach applied to gynecological ultrasound to predict progression-free survival in ovarian cancer patients. PG - 2143-2154 LID - 10.1007/s00404-022-06578-1 [doi] AB - In a growing number of social and clinical scenarios, machine learning (ML) is emerging as a promising tool for implementing complex multi-parametric decision-making algorithms. Regarding ovarian cancer (OC), despite the standardization of features that can support the discrimination of ovarian masses into benign and malignant, there is a lack of accurate predictive modeling based on ultrasound (US) examination for progression-free survival (PFS). This retrospective observational study analyzed patients with epithelial ovarian cancer (EOC) who were followed in a tertiary center from 2018 to 2019. Demographic features, clinical characteristics, information about the surgery and post-surgery histopathology were collected. Additionally, we recorded data about US examinations according to the International Ovarian Tumor Analysis (IOTA) classification. Our study aimed to realize a tool to predict 12 month PFS in patients with OC based on a ML algorithm applied to gynecological ultrasound assessment. Proper feature selection was used to determine an attribute core set. Three different machine learning algorithms, namely Logistic Regression (LR), Random Forest (RFF), and K-nearest neighbors (KNN), were then trained and validated with five-fold cross-validation to predict 12 month PFS. Our analysis included n. 64 patients and 12 month PFS was achieved by 46/64 patients (71.9%). The attribute core set used to train machine learning algorithms included age, menopause, CA-125 value, histotype, FIGO stage and US characteristics, such as major lesion diameter, side, echogenicity, color score, major solid component diameter, presence of carcinosis. RFF showed the best performance (accuracy 93.7%, precision 90%, recall 90%, area under receiver operating characteristic curve (AUROC) 0.92). We developed an accurate ML model to predict 12 month PFS. CI - (c) 2022. The Author(s). FAU - Arezzo, Francesca AU - Arezzo F AUID- ORCID: 0000-0002-8914-9594 AD - Department of Biomedical Sciences and Human Oncology, Obstetrics and Gynecology Unit, University of Bari "Aldo Moro", Piazza Giulio Cesare 11, 70124, Bari, Italy. francesca.arezzo@uniba.it. FAU - Cormio, Gennaro AU - Cormio G AD - Department of Biomedical Sciences and Human Oncology, Obstetrics and Gynecology Unit, University of Bari "Aldo Moro", Piazza Giulio Cesare 11, 70124, Bari, Italy. FAU - La Forgia, Daniele AU - La Forgia D AD - Department of Breast Radiology, Giovanni Paolo II I.R.C.C.S. Cancer Institute, via Orazio Flacco 65, 70124, Bari, Italy. FAU - Santarsiero, Carla Mariaflavia AU - Santarsiero CM AD - Department of Biomedical Sciences and Human Oncology, Obstetrics and Gynecology Unit, University of Bari "Aldo Moro", Piazza Giulio Cesare 11, 70124, Bari, Italy. FAU - Mongelli, Michele AU - Mongelli M AD - Department of Biomedical Sciences and Human Oncology, Obstetrics and Gynecology Unit, University of Bari "Aldo Moro", Piazza Giulio Cesare 11, 70124, Bari, Italy. FAU - Lombardi, Claudio AU - Lombardi C AD - Department of Biomedical Sciences and Human Oncology, Obstetrics and Gynecology Unit, University of Bari "Aldo Moro", Piazza Giulio Cesare 11, 70124, Bari, Italy. FAU - Cazzato, Gerardo AU - Cazzato G AD - Department of Emergency and Organ Transplantation, Pathology Section, University of Bari "Aldo Moro", Piazza Giulio Cesare 11, 70124, Bari, Italy. FAU - Cicinelli, Ettore AU - Cicinelli E AD - Department of Biomedical Sciences and Human Oncology, Obstetrics and Gynecology Unit, University of Bari "Aldo Moro", Piazza Giulio Cesare 11, 70124, Bari, Italy. FAU - Loizzi, Vera AU - Loizzi V AD - Interdisciplinar Department of Medicine, Obstetrics and Gynecology Unit, University of Bari "Aldo Moro", Piazza Giulio Cesare 11, 70124, Bari, Italy. LA - eng PT - Journal Article PT - Observational Study PT - Research Support, Non-U.S. Gov't DEP - 20220509 PL - Germany TA - Arch Gynecol Obstet JT - Archives of gynecology and obstetrics JID - 8710213 SB - IM MH - Humans MH - Female MH - Carcinoma, Ovarian Epithelial/diagnostic imaging MH - Progression-Free Survival MH - *Machine Learning MH - *Ovarian Neoplasms/diagnostic imaging/surgery/pathology MH - Ultrasonography PMC - PMC9633520 OTO - NOTNLM OT - Gynecological ultrasound OT - Machine learning OT - Ovarian cancer OT - Progression-free survival COIS- The authors have no relevant financial or non-financial interests to disclose. EDAT- 2022/05/10 06:00 MHDA- 2022/11/08 06:00 PMCR- 2022/05/09 CRDT- 2022/05/09 11:14 PHST- 2022/02/21 00:00 [received] PHST- 2022/04/12 00:00 [accepted] PHST- 2022/05/10 06:00 [pubmed] PHST- 2022/11/08 06:00 [medline] PHST- 2022/05/09 11:14 [entrez] PHST- 2022/05/09 00:00 [pmc-release] AID - 10.1007/s00404-022-06578-1 [pii] AID - 6578 [pii] AID - 10.1007/s00404-022-06578-1 [doi] PST - ppublish SO - Arch Gynecol Obstet. 2022 Dec;306(6):2143-2154. doi: 10.1007/s00404-022-06578-1. Epub 2022 May 9.